Huntington disease

Search Trials
A Study of Treatment With Pridopidine (ACR16) in Patients With Huntington’s Disease
Status:
Completed
Last Changed:
Jan 1, 1970
First Changed:
Jan 1, 1970
Disease(s):
Huntington's Disease
Intervention(s):
ACR16Placebo
Wearable Sensors for Quantitative Assessment of Motor Impairment in Huntington’s Disease Huntington’s Disease
Status:
Recruiting
Last Changed:
Jan 1, 1970
First Changed:
Jan 1, 1970
Disease(s):
Huntington Disease
Intervention(s):
HD Wear
A Study of Pridopidine (ACR16) for the Treatment of Patients With Huntington’s Disease
Status:
Completed
Last Changed:
Jan 1, 1970
First Changed:
Jan 1, 1970
Disease(s):
Huntington Disease
Intervention(s):
ACR16 10 mgACR16 22.5 mgACR16 45 mgPlacebo
Study of Huntington Patients in Connection With European Huntington’s Disease Network (EHDN)
Status:
Unknown status
Last Changed:
Jan 1, 1970
First Changed:
Jan 1, 1970
Disease(s):
Huntington Disease
A Phase 2, to Evaluating the Safety and Efficacy of Pridopidine Versus Placebo for Symptomatic Treatment in Patients With Huntington’s Disease
Status:
Completed
Last Changed:
Jan 1, 1970
First Changed:
Oct 12, 2013
Disease(s):
Huntington's Disease
Intervention(s):
PridopidinePlacebo

Connect. Empower. Inspire.